Left Versus Right: Does Location Matter for Refractory Metastatic Colorectal Cancer Patients in Phase 1 Clinical Trials?
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- September 2018
published in
has subject area
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal
- Antineoplastic Combined Chemotherapy Protocols
- Cetuximab
- Colorectal Neoplasms
- Drug Resistance, Neoplasm
- Female
- Humans
- Male
- Middle Aged
- Mutation
- Neoplasm Metastasis
- Panitumumab
- Prognosis
- Proto-Oncogene Proteins p21(ras)
- Retrospective Studies
- Survival Analysis